210 related articles for article (PubMed ID: 21161369)
1. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis.
Zhou P; Du LF; Lv GQ; Yu XM; Gu YL; Li JP; Zhang C
Breast Cancer Res Treat; 2011 Jun; 127(3):813-8. PubMed ID: 21161369
[TBL] [Abstract][Full Text] [Related]
2. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis].
Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.
Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S
Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009
[TBL] [Abstract][Full Text] [Related]
4. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM
Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
[TBL] [Abstract][Full Text] [Related]
6. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
Peng B; Cao L; Wang W; Xian L; Jiang D; Zhao J; Zhang Z; Wang X; Yu L
Mutagenesis; 2010 Jan; 25(1):41-8. PubMed ID: 19843588
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
[TBL] [Abstract][Full Text] [Related]
9. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J
Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298
[TBL] [Abstract][Full Text] [Related]
10. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.
Hughes S; Agbaje O; Bowen RL; Holliday DL; Shaw JA; Duffy S; Jones JL
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6673-80. PubMed ID: 18006768
[TBL] [Abstract][Full Text] [Related]
12. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility.
Zhu Y; Spitz MR; Lei L; Mills GB; Wu X
Cancer Res; 2001 Nov; 61(21):7825-9. PubMed ID: 11691799
[TBL] [Abstract][Full Text] [Related]
13. Association Study of Matrix Metalloproteinases Gene Polymorphisms with Susceptibility to Rheumatoid Arthritis: A Meta-Analysis.
Li P; Tao SS; Zhao MQ; Li J; Wang X; Pan HF; Ye DQ
Immunol Invest; 2015; 44(7):603-15. PubMed ID: 26436849
[TBL] [Abstract][Full Text] [Related]
14. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects.
Yu KD; Di GH; Fan L; Chen AX; Yang C; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205
[TBL] [Abstract][Full Text] [Related]
15. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer.
Liu L; Wu J; Wu C; Wang Y; Zhong R; Zhang X; Tan W; Nie S; Miao X; Lin D
Cancer; 2011 Nov; 117(22):5172-81. PubMed ID: 21523769
[TBL] [Abstract][Full Text] [Related]
16. Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis.
Zhang C; Lv GQ; Yu XM; Gu YL; Li JP; Du LF; Zhou P
Breast Cancer Res Treat; 2011 Jul; 128(2):467-72. PubMed ID: 21221763
[TBL] [Abstract][Full Text] [Related]
17. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
[TBL] [Abstract][Full Text] [Related]
18. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH
Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933
[TBL] [Abstract][Full Text] [Related]
19. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]